3
Clinical Trials associated with Allogeneic Endothelial Progenitor Cells(Allife Medical Science and Technology)Phase I Clinical Study on the Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) Injection in Patients With Critical Limb Ischemia
The purpose of this study is to determine if allogeneic Endothelial Progenitor Cells (EPCs) intravenous infusion to a subject with leg ulcer and/or gangrene due to poor blood flow will be safe and if it will relieve leg pain, increase blood flow, and/or cure the leg wound.
Phase I Clinical Study on the Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) Injection in Patients with Acute Ischemic Stroke
This is a multicenter, randomized, double-blind, placebo-controlled, dose-Escalation clinical study to investigate the safety and efficacy of EPCs transplantation in Acute ischemic stroke.
A Safety and Efficacy Study of Human Peripheral Blood Derived Induced EPCs for Cerebral Hemorrhagic Stroke
This is a single centre、single arm、open-label,to investigate the safety and efficacy of EPC transplantation in the brain
100 Clinical Results associated with Allogeneic Endothelial Progenitor Cells(Allife Medical Science and Technology)
100 Translational Medicine associated with Allogeneic Endothelial Progenitor Cells(Allife Medical Science and Technology)
100 Patents (Medical) associated with Allogeneic Endothelial Progenitor Cells(Allife Medical Science and Technology)
100 Deals associated with Allogeneic Endothelial Progenitor Cells(Allife Medical Science and Technology)